The effect of USP21 deletion in cancer cells was studied in CRISPR/Cas9-edited USP21-targeting HAP-1 cells (HAP-1 USP21 KO) in comparison to HAP-1 parental control (HAP-1 WT). This evidence concerns the gene USP21 and cancer.